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Abstract
Introduction: Pancreatic adenocarcinoma is extremely rare in childhood. We report a case of metastatic pancreatic
adenocarcinoma in a 13-year-old boy, revealed by jaundice.
Case presentation: A 13-year-old Moroccan boy was admitted with obstructive jaundice to the children’s Hospital
of Rabat, Department of Pediatric Oncology. Laboratory study results showed a high level of total and conjugated
bilirubin. Computerized tomography of the abdomen showed a dilatation of the intra-hepatic and extra-hepatic
bile ducts with a tissular heterogeneous tumor of the head of the pancreas and five hepatic lesions. Biopsy of a
liver lesion was performed, and a histopathological examination of the sample confirmed the diagnosis of
metastatic ductal adenocarcinoma of the pancreas. Our patient underwent a palliative biliary derivation. After that,
chemotherapy was administered (5-fluorouracil and epirubicin), however no significant response to treatment was
noted and our patient died six months after diagnosis.
Conclusion: Malignant pancreatic tumors, especially ductal carcinomas, are exceedingly rare in the pediatric age
group and their clinical features and treatment usually go unappreciated by most pediatric oncologists and
surgeons.
Introduction
Beyond infancy obstructive jaundice is rarely encoun-
tered among children [1], and the pancreas is an extre-
mely uncommon site of neoplasia in children and
adolescents [2,3]. For this reason, our understanding of
these tumors is still quite limited.
Case presentation
A 13-year-old Moroccan boy was admitted with
obstructive jaundice to the Children’s Hospital of Rabat,
Department of Pediatric Oncology. He had an illness of
two months’ duration that presented with jaundice,
weight loss, melena and hematemesis. On physical
examination, our patient had jaundice with hepatosple-
nomegaly. Laboratory study results showed a total bilir-
ubin level of 26 mg/dL with a conjugated bilirubin of 18
mg/dL (normal level < 0.7 mg/dL), aspartate amino-
transferase and alanine aminotransferase levels of 220
and 250IU/L, respectively (normal level < 45IU/L), and
a hemoglobin level of 9 g/mL. Abdominal ultrasonogra-
phy showed a dilatation of intra-hepatic and extra-hepa-
tic bile ducts and hepatomegaly. Computerized
tomography of the abdomen showed a dilatation of
intra-hepatic and extra-hepatic bile ducts with a tissular
heterogeneous tumor of the head of the pancreas mea-
suring 49/37 mm (Figure 1A, B) and five metastatic
lesions of the liver (Figure 2). Biopsy of one of the liver
lesions was performed, and a histopathological examina-
tion of the sample confirmed the diagnosis of metastatic
ductal adenocarcinoma of the pancreas. Our patient
underwent a palliative biliary derivation. Chemotherapy
was administered (5-fluorouracil and epirubicin); how-
ever, no significant response to treatment was seen and
our patient died six months after diagnosis.
Discussion
Pancreatic tumors in childhood most commonly present
with a palpable mass or with pain [3]. Jaundice occurs
much less commonly than in adults [3]. Tumors of the
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The following tumor types are described in children
and adolescents: ductal adenocarcinoma, acinar cell
carcinoma, pancreatoblastoma, solid pseudopapillary
tumor, and pancreatic endocrine neoplasms (benign
and malignant) [4]. In addition, there are reported
cases of other tumor types, which either arise within
the mass of the pancreas from other non-pancreatic
cell types or immediately adjacent to it or involve the
gland secondarily. Classic ductal adenocarcinoma of
the pancreas, the common type in adults, is extremely
rare in childhood. Most cases are in older literature.
To examine the incidence trends and outcomes for
children with pancreatic malignancies, the Surveillance,
Epidemiology, and End Results Registry (1973 to 2004)
was examined for pediatric patients with pancreatic
malignancies (up to 19 years of age) [5]. Malignant
pancreatic neoplasms were identified in 58 patients.
Women outnumbered men 1.9:1 (38 versus 20) for an
age population-adjusted incidence of 0.021 and 0.015
per 100,000. Ductal adenocarcinoma, was identified in
seven patients. A 90-year (1918 to 2007), single institu-
tion, retrospective review of all patients with neoplastic
pancreatic masses was performed and published
recently [6]. Eighteen patients were identified with
seven distinct histopathological subtypes. The most
common were gastroenteropancreatic neuroendocrine,
solid pseudopapillary, and acinar tumors. There were 6
benign and 12 malignant tumors. Surgery remains the
keystone of treatment for pancreatic tumors in the
pediatric age group, as in adults [7]. Long-term dis-
ease-free survival in childhood pancreatic malignancies
is achievable with complete surgical resection [6].
There is no proven role for chemotherapy or radiation
[4]. The information available in the literature, particu-
larly with regard to the role of chemotherapy and
radiation, is anecdotal [4]. These modalities should be
reserved in unresectable and metastatic disease. Finally,
it appears that ductal adenocarcinoma has a worse
prognosis. According to a recent study, there was a
significant difference in tumor type 15-year survival
with ductal adenocarcinoma having the worst (23%)
and solid cystic tumor the best (100%) [5].
Conclusions
Malignant pancreatic tumors especially ductal carcino-
mas are exceedingly rare in the pediatric age group and
their clinical features and treatment usually go unappre-
ciated by most pediatric oncologists and surgeons.
Consent
Written informed consent was obtained from the
patient’s next-of-kin for publication of this case report
and any accompanying images. A copy of the written
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Figure 1 Metastatic pancreatic adenocarcinoma in our 13-year-
old patient. A computerized tomography (CT) scan of the
abdomen showed a tissular heterogeneous tumor of the head of
the pancreas measuring 49 mm × 37 mm.
Figure 2 Computerized tomography (CT) scan revealing
metastatic lesions of the liver.
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